La Jolla Pharmaceutical Company

NasdaqCM:LJPC Stock Report

Market Cap: US$155.1m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La Jolla Pharmaceutical Management

Management criteria checks 3/4

La Jolla Pharmaceutical's CEO is Larry Edwards, appointed in Jul 2020, has a tenure of 2.08 years. total yearly compensation is $2.39M, comprised of 23% salary and 77% bonuses, including company stock and options. directly owns 0.048% of the company’s shares, worth $74.45K. The average tenure of the management team and the board of directors is 2.1 years and 7.7 years respectively.

Key information

Larry Edwards

Chief executive officer

US$2.4m

Total compensation

CEO salary percentage23.0%
CEO tenure2.1yrs
CEO ownership0.05%
Management average tenure2.1yrs
Board average tenure7.7yrs

Recent management updates

Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Jan 05
Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Recent updates

Innoviva to acquire La Jolla Pharma for $149M including debt

Jul 11

We Think La Jolla Pharmaceutical's (NASDAQ:LJPC) Robust Earnings Are Conservative

Nov 11
We Think La Jolla Pharmaceutical's (NASDAQ:LJPC) Robust Earnings Are Conservative

Our Take On La Jolla Pharmaceutical Company

Jul 02

La Jolla Pharmaceutical EPS misses by $0.14, beats on revenue

May 07

La Jolla Pharmaceutical's (NASDAQ:LJPC) Shareholders Are Down 82% On Their Shares

Mar 11
La Jolla Pharmaceutical's (NASDAQ:LJPC) Shareholders Are Down 82% On Their Shares

Market Sentiment Around Loss-Making La Jolla Pharmaceutical Company (NASDAQ:LJPC)

Feb 11
Market Sentiment Around Loss-Making La Jolla Pharmaceutical Company (NASDAQ:LJPC)

Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18%

Jan 16
Industry Analysts Just Upgraded Their La Jolla Pharmaceutical Company (NASDAQ:LJPC) Revenue Forecasts By 18%

La Jolla Pharmaceutical rallies on exclusive licensing agreement with PAION

Jan 12

Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Jan 05
Should You Take Comfort From Insider Transactions At La Jolla Pharmaceutical Company (NASDAQ:LJPC)?

Could The La Jolla Pharmaceutical Company (NASDAQ:LJPC) Ownership Structure Tell Us Something Useful?

Dec 09
Could The La Jolla Pharmaceutical Company (NASDAQ:LJPC) Ownership Structure Tell Us Something Useful?

La Jolla Pharmaceutical EPS beats by $0.11, beats on revenue

Nov 09

CEO Compensation Analysis

How has Larry Edwards's remuneration changed compared to La Jolla Pharmaceutical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

US$4m

Mar 31 2022n/an/a

US$5m

Dec 31 2021US$2mUS$550k

US$20m

Sep 30 2021n/an/a

US$12m

Jun 30 2021n/an/a

US$3m

Mar 31 2021n/an/a

-US$16m

Dec 31 2020US$3mUS$208k

-US$39m

Compensation vs Market: Larry's total compensation ($USD2.39M) is above average for companies of similar size in the US market ($USD1.53M).

Compensation vs Earnings: Larry's compensation has been consistent with company performance over the past year.


CEO

Larry Edwards (50 yo)

2.1yrs

Tenure

US$2,389,409

Compensation

Mr. Larry G. Edwards has been President and Chief Executive Officer at La Jolla Pharmaceutical Company since July 2020. Mr. Edwards serves as Director at La Jolla Pharmaceutical Company since October 29, 2...


Leadership Team

NamePositionTenureCompensationOwnership
Larry Edwards
President2.1yrsUS$2.39m0.048%
$ 74.5k
Michael Hearne
CFO & Secretary2.2yrsUS$504.10k0.041%
$ 63.4k
Paula Rusu
Vice President of Operations1.8yrsno datano data
Sandra Vedrick
Senior Director of Investor Relations & Human Resourcesno datano datano data
Luke Seikkula
Senior Vice President of Pharmaceutical Operations3.5yrsno datano data
Lakhmir Chawla
Consultant7.1yrsUS$707.29kno data
Stewart Kroll
Chief Development Officer2.7yrsno datano data
Mark Williams
Senior Vice President of Medical Affairs1.9yrsno datano data
Tony Hodges
Chief Medical Officerless than a yearno datano data

2.1yrs

Average Tenure

58yo

Average Age

Experienced Management: LJPC's management team is considered experienced (2.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Larry Edwards
President1.8yrsUS$2.39m0.048%
$ 74.5k
Kevin Tang
Chairman of the Board8yrsUS$105.86k0.45%
$ 696.6k
David Ramsay
Independent Director2.8yrsUS$165.86k0.40%
$ 622.0k
Tomas Ganz
Member of Scientific Advisory Board8.5yrsno datano data
Laura Douglass
Independent Director8.8yrsUS$165.86k0.0020%
$ 3.1k
Elizabeta Nemeth
Member of Scientific Advisory Board8.5yrsno datano data
Craig Johnson
Independent Director8.8yrsUS$180.86k0.048%
$ 74.6k
Robert Rosen
Independent Director8.1yrsUS$165.86k0%
$ 0
Paul Adams
Member of Advisory Board7.3yrsno datano data
Victor Gordeuk
Member of Advisory Board7.3yrsno datano data
Ashutosh Lal
Member of Advisory Board7.3yrsno datano data
Gordon McLaren
Member of Advisory Board7.3yrsno datano data

7.7yrs

Average Tenure

57yo

Average Age

Experienced Board: LJPC's board of directors are considered experienced (7.7 years average tenure).